Vet-Stem, the innovator in veterinary regenerative cell medicine, is now using its Vet-Stem Regenerative Cell (VSRC) therapy to treat osteoarthritis in dogs. Vet-Stem’s VSRC therapy has demonstrated successful therapeutic outcomes in horses with tendon and ligament injuries, fractures, and joint disease.
Since 2005, selected clinics have treated dogs with osteoarthritis and orthopedic soft tissue injuries. Initial studies demonstrate that intra-articular administration of VSRCs significantly decreases pain and improves comfort in the majority of cases. Duration of the benefit from a single injection varies from several months to more than 1 year.
Clinical trials for osteoarthritis of the canine elbow, hip, and stifle are ongoing with successful results soon to be published.
Besides the overwhelming scientific data demonstrating the clinical efficacy of regenerative cellular therapy in animal models of osteoarthritis, osteochondral defects, tendon repair, and fractures, many additional studies demonstrate success in treating systemic disorders such as cerebral and myocardial infarction, muscular dystrophy, and immune-mediated disorders. Based on these studies, Vet-Stem is developing protocols to treat internal medicine conditions.
ABC News (01/09/08)
The Raw Story/Nightline (video) (01/10/08)